Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis-Reference-Cited by-同舟云学术

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

Published:2014-02-28 Issue:2 Volume:9 Page:e90176
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chai Louis Yi Ann,Kullberg Bart Jan,Earnest Arul,Johnson Elizabeth M.,Teerenstra Steven,Vonk Alieke G.,Schlamm Haran T.,Herbrecht Raoul,Netea Mihai G.,Troke Peter F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference19 articles.

1. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid;B Musher;J Clin Microbiol,2004

2. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group;B De Pauw;Clin Infect Dis,2008

3. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay;JA Maertens;Clin Infect Dis,2007

4. Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease;F Boutboul;Clin Infect Dis,2002

5. Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis;LY Chai;J Clin Microbiol,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Invasive Mold Diseases;Infection & Chemotherapy;2023

2. Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases;Open Forum Infectious Diseases;2022-03-04

3. Cost-Effectiveness of Serum Galactomannan Surveillance during Mould-Active Antifungal Prophylaxis;Journal of Fungi;2021-05-26

4. Usefulness of serum galactomannan in initiating and modifying antifungal therapy in children with cancer and persistent high‐risk febrile neutropenia;Mycoses;2020-05-28

5. Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis;Mycoses;2019-08-18